Page last updated: 2024-09-05

tv3326 and vilazodone

tv3326 has been researched along with vilazodone in 1 studies

Compound Research Comparison

Studies
(tv3326)
Trials
(tv3326)
Recent Studies (post-2010)
(tv3326)
Studies
(vilazodone)
Trials
(vilazodone)
Recent Studies (post-2010) (vilazodone)
1501115011

Protein Interaction Comparison

ProteinTaxonomytv3326 (IC50)vilazodone (IC50)
5-hydroxytryptamine receptor 1AHomo sapiens (human)0.0002
5-hydroxytryptamine receptor 2CRattus norvegicus (Norway rat)2
Alpha-2A adrenergic receptorHomo sapiens (human)6
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)1.51
Alpha-2B adrenergic receptorHomo sapiens (human)6
Alpha-2C adrenergic receptorHomo sapiens (human)6
D(3) dopamine receptorRattus norvegicus (Norway rat)0.071
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.0003
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.1581
Alpha-1D adrenergic receptorHomo sapiens (human)1.98
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)5
5-hydroxytryptamine receptor 1DRattus norvegicus (Norway rat)4
D(4) dopamine receptorRattus norvegicus (Norway rat)3.4
5-hydroxytryptamine receptor 6Rattus norvegicus (Norway rat)3
Sodium-dependent serotonin transporterHomo sapiens (human)0.0004
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)0.0067
5-hydroxytryptamine receptor 7 Rattus norvegicus (Norway rat)3
Alpha-1A adrenergic receptorHomo sapiens (human)1.98
Alpha-1B adrenergic receptorHomo sapiens (human)1.98
5-hydroxytryptamine receptor 3ARattus norvegicus (Norway rat)4.3
D(2) dopamine receptorRattus norvegicus (Norway rat)0.666
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.0003
Sodium-dependent dopamine transporter Homo sapiens (human)0.295
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)5.575
5-hydroxytryptamine receptor 4 Rattus norvegicus (Norway rat)0.252
5-hydroxytryptamine receptor 3BRattus norvegicus (Norway rat)4.3

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumar, A; Mishra, P; Panda, G1

Reviews

1 review(s) available for tv3326 and vilazodone

ArticleYear
Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018).
    Bioorganic & medicinal chemistry, 2019, 03-15, Volume: 27, Issue:6

    Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Cholinesterases; Drug Design; Humans; Ligands; Neuroprotective Agents

2019